Johnson & Johnson MedTech (NYSE: JNJ) announced that it received CE mark approval for its dual-energy ThermoCool SmartTouch ...
The Medtronic Harmony transcatheter pulmonary valve system provides a minimally invasive alternative for congenital heart ...
Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has announced that its ...
GlobalData on MSN2d
The impact of regulation and AI on Europe’s medical device trial landscapeIn recent years, new regulation has been top-of-mind for medtech companies wishing to continue marketing their products in ...
Hosted on MSN2d
BTIG Downgrades Inari Medical (NARI)Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.
Q2 2025 Earnings Call Transcript January 8, 2025 AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.04, ...
TRiCares is also making progress in Europe, with growing patient enrollment in its TRICURE EU Pivotal study, with the first ...
Paris, France and Munich, Germany, January 09, 2025 - TRiCares SAS ("TRiCares"), a company pioneering a minimally-invasive tricuspid valve that flexes with every heartbeat, announces that the first ...
The UK has decided to continue recognising the CE mark, however, both sides need to agree on a common way to describe ...
Timing is everything. Just days after confirming a pause in the U.S. rollout of its Varipulse pulsed field ablation (PFA) catheter, Johnson & Johnson’s electrophysiology program received an epic ...
Harmony™ Transcatheter Pulmonary Valve system received approval for minimally invasive treatment option for patients with ...
Medtronic plc received CE mark approval for its Harmony transcatheter pulmonary valve system to treat congenital heart disease patients with native or surgically repaired right ventricular outflow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback